Skip to the page

Data / Drug companies / AvPAK

AvPAK: 344 products in the FDA NDC directory, labeler code 50268

AvPAK (labeler code 50268) lists 344 products in the FDA National Drug Code Directory, covering 179 finished drugs by generic name. By type: 327 prescription drugs, 17 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 27, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
50268
Products in commercial distribution
344
Packages
352
Finished drugs by generic name
179
Prescription products
327
Over the counter products
17
Controlled substance products
Schedule II 6, Schedule III 5, Schedule IV 11, Schedule V 7
Flagged as original packager
41 of 41 products that carry the flag
Started marketing in the last 12 months
24
Products with a marketing end date set
2
Earliest marketing start
February 25, 2003
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)32293.6%
Over the counter monograph drugs154.4%
Other unapproved drugs61.7%
Authorized generics (NDA)10.3%

Products by type

TypeProductsShare
Prescription drugs32795.1%
Over the counter drugs174.9%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Aripiprazole649
Quetiapine fumarate633
Amitriptyline hydrochloride535
Pregabalin554
Chlorpromazine hydrochloride527
Atorvastatin calcium459
Metoprolol succinate446
Pravastatin sodium439
Valsartan438
Torsemide425
Carbamazepine452
Capsaicin466
Doxazosin428
Ropinirole hydrochloride49
Terazosin hydrochloride415
Ziprasidone hcl46
Bupropion hydrochloride467
Topiramate456
Benazepril hydrochloride424
Fluphenazine hydrochloride429
Atomoxetine hydrochloride38
Clonazepam336
Clonidine hydrochloride345
Oxycodone and acetaminophen332
Oxcarbazepine346
Sertraline hydrochloride355
Baclofen365
Bumetanide342
Doxycycline hyclate361
Fenofibrate356
Hydrocodone bitartrate and acetaminophen337
Paroxetine333
Propranolol hydrochloride351
Rosuvastatin319
Carboxymethylcellulose sodium330
Losartan potassium343
Midodrine hydrochloride334
Potassium chloride384
Hydrocortisone3171
Nifedipine338
Alprazolam337
Glimepiride332
Isosorbide dinitrate318
Sacubitril and valsartan329
Oxybutynin chloride345
Venlafaxine hydrochloride348
Sertraline313
Buprenorphine and naloxone222
Clarithromycin227
Fluconazole248
Montelukast sodium231
Naproxen258
Methocarbamol267
Memantine hydrochloride236
Nitrofurantoin macrocrystals220
Primidone223
Sirolimus222
Sotalol hydrochloride225
Doxycycline263
Famotidine2138
Flecainide acetate213
Indomethacin236
Methimazole223
Ursodiol228
Acyclovir270
Buprenorphine224
Flucytosine210
Meloxicam254
Metronidazole268
Metformin hydrochloride279
Ondansetron hydrochloride248
Tizanidine238
Valacyclovir hydrochloride228
Allopurinol254
Cilostazol210
Sodium citrate and citric acid monohydrate26
Divalproex sodium248
Leflunomide219
Mycophenolate mofetil237
Temazepam228
Urea217
Cephalexin236
Celecoxib263
Hydroxyzine pamoate230
Prochlorperazine maleate231
Glipizide239
Lacosamide257
Ranolazine230
Tacrolimus235
Pantoprazole sodium254
Modafinil225
Acetazolamide137
Anastrozole122
Dicyclomine hydrochloride150
Gabapentin191
Posaconazole129
Tramadol hydrochloride and acetaminophen113
Valganciclovir114
Abacavir18
Polyethylene glycol 400 and propylene glycol12

Dosage forms

Dosage formProductsShare
Tablet14341.6%
Tablet, film coated8023.3%
Capsule5315.4%
Tablet, extended release102.9%
Tablet, film coated, extended release92.6%
Solution92.6%
Capsule, extended release92.6%
Tablet, delayed release51.5%
Cream51.5%
Solution/ drops41.2%
Tablet, coated20.6%
Tablet, chewable20.6%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Sirolimus50268-827Tablet, film coatedGeneric drugs (ANDA)October 27, 2026
Acamprosate Calcium50268-028Tablet, delayed releaseGeneric drugs (ANDA)October 26, 2026
Allopurinol50268-031TabletGeneric drugs (ANDA)October 6, 2026
Allopurinol50268-030TabletGeneric drugs (ANDA)October 6, 2026
Lacosamide50268-492TabletGeneric drugs (ANDA)September 29, 2026
Lacosamide50268-491TabletGeneric drugs (ANDA)September 29, 2026
Tacrolimus50268-737CapsuleGeneric drugs (ANDA)September 20, 2026
Tacrolimus50268-736CapsuleGeneric drugs (ANDA)September 20, 2026
Pantoprazole sodium50268-727Tablet, delayed releaseGeneric drugs (ANDA)August 26, 2026
Ursodiol50268-864CapsuleGeneric drugs (ANDA)July 14, 2026
Carbidopa and Levodopa50268-202TabletGeneric drugs (ANDA)June 23, 2026
Topiramate50268-809Tablet, film coatedGeneric drugs (ANDA)June 8, 2026
Topiramate50268-808Tablet, film coatedGeneric drugs (ANDA)June 8, 2026
Topiramate50268-807Tablet, film coatedGeneric drugs (ANDA)June 8, 2026
Topiramate50268-806Tablet, film coatedGeneric drugs (ANDA)June 8, 2026
Calcium Acetate50268-203CapsuleGeneric drugs (ANDA)May 28, 2026
Loratadine50268-777TabletGeneric drugs (ANDA)May 21, 2026
Ramelteon50268-822TabletGeneric drugs (ANDA)May 20, 2026
Abiraterone Acetate50268-032TabletGeneric drugs (ANDA)May 4, 2026
Esomeprazole Magnesium50268-272Capsule, delayed releaseGeneric drugs (ANDA)March 23, 2026
Cinacalcet50268-188Tablet, film coatedGeneric drugs (ANDA)March 16, 2026
Phenytoin Sodium50268-719Capsule, extended releaseGeneric drugs (ANDA)March 3, 2026
Methotrexate50268-554TabletGeneric drugs (ANDA)January 29, 2026
Amantadine50268-036SolutionGeneric drugs (ANDA)January 19, 2026
Cyproheptadine Hydrochloride50268-201TabletGeneric drugs (ANDA)October 30, 2025

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.